Data from An Immune-Inflammation Gene Expression Signature in Prostate Tumors of Smokers
Robyn L. Prueitt(Gradient (United States)), Stefan Ambs(University of Maryland, Baltimore), James F. Borin, Nagireddy Putluri(Baylor College of Medicine), Robert Hudson(National Cancer Institute), Sharon A. Glynn(Ollscoil na Gaillimhe – University of Galway), Jennifer L. Shoe(Leidos (United States)), Arun Sreekumar(University of Michigan–Ann Arbor), Atsushi Terunuma(Yotsuya Medical Cube), Harris G. Yfantis(University of Maryland, Baltimore), Diana C. Haines(Leidos (United States)), Tiffany H. Dorsey(Center for Cancer Research), Michael J. Naslund(University of Maryland, Baltimore), Tiffany A. Wallace(University of Florida), Christopher A. Loffredo(Georgetown University), Jun Luo(Central South University), Wei Tang(Yunnan University), Ming Yi(Science Applications International Corporation (United States)), Robert M. Stephens(National Cancer Institute), John W. Gillespie(National Cancer Institute), Misop Han(Johns Hopkins University), Richard B. Alexander, Symone V. Jordan(Center for Cancer Research), Arthur A. Hurwitz(SUNY Upstate Medical University), Katherine E. Stagliano(National Institutes of Health), Dong Hoon Lee(Korea University), Damali N. Martin(National Institutes of Health)
Cited by 0
Related Papers
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
|Cancer Research|2008|708
Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men
|Cancer Research|2008|522
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
|Journal of Clinical Investigation|2013|469